Bengaluru, India

Srinivas Kalidindi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Bristol-Myers Squibb Compnay, Syngene International Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinivas Kalidindi. Retrieved from https://idiyas.com/inventor/srinivas-kalidindi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Srinivas Kalidindi

Introduction

Srinivas Kalidindi is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of synthetic processes, particularly in the preparation of compounds with RORγt antagonist properties. His work has implications in various pharmaceutical applications.

Latest Patents

Srinivas holds a patent for a synthetic process that relates to preparing compounds, including a compound of Formula (I). This invention is particularly useful as a key intermediate in the development of compounds with specific biological activities.

Career Highlights

Throughout his career, Srinivas has worked with prominent companies such as Bristol-Myers Squibb Company and Syngene International Limited. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects in the pharmaceutical industry.

Collaborations

Srinivas has collaborated with notable professionals in his field, including William P. Gallagher and John Ryan Coombs. These collaborations have enriched his work and expanded the impact of his inventions.

Conclusion

Srinivas Kalidindi's contributions to synthetic processes and his collaborations with leading professionals highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…